Nirsevimab Library
This is a collection of current resources related to Nirsevimab.
Beyfortus (nirsevimab) Now Available Through VFC
This announcement explains that providers can order nirsevimab (Beyfortus) through Vaccines for Children (VFC). It covers the following areas of consideration: dosage and administration, eligible …
Ask aRCie
5 Tips on Buying Beyfortus (nirsevimab-alip) for Babies
2024
· PracticeWell
This webpage explains how to order Beyfortus, a monoclonal antibody that may prevent young infants from getting respiratory syncytial virus (RSV). It covers discounts, reimbursements, …
ACOG, SMFM, and AAP Statement on Nirsevimab Shortage
This statement describes a shortage of nirsevimab and provides further recommendations. ACOG and SMFM recommend Pfizer’s RSVpreF vaccine for pregnant women as an alternative. Pediatricians …
Nirsevimab Monoclonal Antibody Memo (2024-2025)
This memo outlines recommendations and an implementation plan for nirsevimab (Beyfortus™), a long-acting monoclonal antibody effective against respiratory syncytial virus (RSV), at Lucile Packard Children’s …
Nirsevimab (Beyfortus) Guide to Prevent Severe RSV in Infants and Toddlers
This one-page infographic provides guidance on using nirsevimab (Beyfortus) to prevent severe RSV in infants and toddlers. It addresses high-risk conditions in children, as well …
Beyfortus® For Prevention of Respiratory Syncytial Virus (RSV) in Infants
This webpage provides a pharmacy update on the use of Beyfortus for the prevention of RSV in infants. The FDA approved nirsevimab for infants and …
Guidelines for Inpatient Administration of Nirsevimab to Infants and Children
2024
· University of Michigan
This 4-page document explain how to give nirsevimab to infants and children in hospitals. It describes dosing based on age and weight, especially after heart …
News & Views: Nirsevimab Means Brushing Up on Passive Immunity Talking Points
This post is about nirsevimab, a new treatment that helps protect babies from respiratory illnesses. It describes how nirsevimab provides passive immunity, which means it …